Contrasting Evidence to Reimbursement Reality for Off-label use (OLU) of Drug Treatments in Cancer Care – Rationale and Design of the CEIT-OLU-project
View ORCID ProfileAK Herbrand, AM Schmitt, M Briel, S Diem, H Ewald, A Hoogkamer, M Joerger, KA Mc Cord, U Novak, S Sricharoenchai, LG Hemkens, B Kasenda
doi: https://doi.org/10.1101/19003152
AK Herbrand
1Department of Medical Oncology, University Hospital Basel and University of Basel, Basel, Switzerland
AM Schmitt
1Department of Medical Oncology, University Hospital Basel and University of Basel, Basel, Switzerland
M Briel
2Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland
3Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
S Diem
4Department of Oncology and Hematology, Spital Grabs, Grabs, Switzerland
5Department of Oncology and Hematology, Cantonal Hospital, St. Gallen, St. Gallen, Switzerland
6Department of Immunobiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
H Ewald
2Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland
7University Medical Library, University of Basel, Basel, Switzerland
A Hoogkamer
1Department of Medical Oncology, University Hospital Basel and University of Basel, Basel, Switzerland
M Joerger
5Department of Oncology and Hematology, Cantonal Hospital, St. Gallen, St. Gallen, Switzerland
KA Mc Cord
2Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland
U Novak
8Department of Medical Oncology, Bern University Hospital, Bern, Switzerland
S Sricharoenchai
2Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland
LG Hemkens
2Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland
B Kasenda
1Department of Medical Oncology, University Hospital Basel and University of Basel, Basel, Switzerland
9Department of Hematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany
Posted July 29, 2019.
Contrasting Evidence to Reimbursement Reality for Off-label use (OLU) of Drug Treatments in Cancer Care – Rationale and Design of the CEIT-OLU-project
AK Herbrand, AM Schmitt, M Briel, S Diem, H Ewald, A Hoogkamer, M Joerger, KA Mc Cord, U Novak, S Sricharoenchai, LG Hemkens, B Kasenda
medRxiv 19003152; doi: https://doi.org/10.1101/19003152
Contrasting Evidence to Reimbursement Reality for Off-label use (OLU) of Drug Treatments in Cancer Care – Rationale and Design of the CEIT-OLU-project
AK Herbrand, AM Schmitt, M Briel, S Diem, H Ewald, A Hoogkamer, M Joerger, KA Mc Cord, U Novak, S Sricharoenchai, LG Hemkens, B Kasenda
medRxiv 19003152; doi: https://doi.org/10.1101/19003152
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2337)
- Dermatology (205)
- Emergency Medicine (374)
- Epidemiology (11705)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3689)
- Geriatric Medicine (345)
- Health Economics (632)
- Health Informatics (2367)
- Health Policy (926)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3452)
- Nursing (195)
- Nutrition (520)
- Oncology (1802)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6092)
- Radiology and Imaging (1257)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)